Gouty cardiomyopathy
Gout is a "crystallization disease" caused by the accumulation and crystallization of urate in the body due to long-term disorder of purine metabolism. In gout patients, heart disease is rarely caused by urate accumulation, crystallization or even stone formation in the heart, but more often it is caused by gout, which is easily combined with coronary atherosclerosis and hypertension.
-
Site of disease:
heart -
Infectious :
Not contagious -
Frequent population:
Most patients develop the disease between the ages of 30 and 40 -
Related symptoms:
Gouty nodules myocardial hypertrophy organic heart disease high blood pressure gouty nodules -
Concurrent disease:
Related Drugs
Simvastatin
Indication: Used to treat hypercholesterolemia and coronary heart disease.
Manufacturer:
Zhejiang Jiangbei Pharmaceutical Co., Ltd.
Simvastatin
Indication: 1. When dietary therapy and other non-drug treatments for hypercholesterolemia are ineffective, simvastatin can be used to reduce total cholesterol and low-density lipoprotein cholesterol in patients with primary hypercholesterolemia. Simvastatin can also increase high-density lipoprotein cholesterol and thus reduce the ratio of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol and total cholesterol/high-density lipoprotein cholesterol. In patients with combined hypercholesterolemia and hypertriglyceridemia, when hypercholesterolemia is the main abnormality, it can reduce elevated cholesterol levels; 2. For patients with coronary heart disease, simvastatin is suitable for: reducing the risk of death; reducing the risk of death from coronary heart disease and non-fatal myocardial infarction; reducing myocardial revascularization surgery (coronary artery bypass grafting and percutaneous balloon coronary angioplasty); delaying the progression of atherosclerosis, including the occurrence of new lesions and total blockage.
Related Ingredients